高级检索
    刘馨屿, 任胜祥, 董嵩. 免疫治疗开启新辅助新篇，精准策略探索前路漫漫——评NSCLC新辅助免疫治疗的机遇与挑战[J]. 循证医学, 2024, 24(1): 12-15. DOI: 10.12019/j.issn.1671-5144.2024.01.002
    引用本文: 刘馨屿, 任胜祥, 董嵩. 免疫治疗开启新辅助新篇，精准策略探索前路漫漫——评NSCLC新辅助免疫治疗的机遇与挑战[J]. 循证医学, 2024, 24(1): 12-15. DOI: 10.12019/j.issn.1671-5144.2024.01.002
    shu
    LIU Xin-yu, REN Sheng-xiang, DONG Song. Immunotherapy Opens a New Chapter of Adjuvant Therapy, and Precise Strategy Exploration Has a Long Way To Go: Comment on the Opportunities and Challenges of Neoadjuvant Immunotherapy in NSCLC[J]. Journal of Evidence-Based Medicine, 2024, 24(1): 12-15. DOI: 10.12019/j.issn.1671-5144.2024.01.002
    Citation: LIU Xin-yu, REN Sheng-xiang, DONG Song. Immunotherapy Opens a New Chapter of Adjuvant Therapy, and Precise Strategy Exploration Has a Long Way To Go: Comment on the Opportunities and Challenges of Neoadjuvant Immunotherapy in NSCLC[J]. Journal of Evidence-Based Medicine, 2024, 24(1): 12-15. DOI: 10.12019/j.issn.1671-5144.2024.01.002
    shu

    免疫治疗开启新辅助新篇，精准策略探索前路漫漫——评NSCLC新辅助免疫治疗的机遇与挑战

    Immunotherapy Opens a New Chapter of Adjuvant Therapy, and Precise Strategy Exploration Has a Long Way To Go: Comment on the Opportunities and Challenges of Neoadjuvant Immunotherapy in NSCLC

      摘要
      • HTML全文
      • 参考文献(16)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回